Outcomes Following Adalimumab Bio-originator to Biosimilar Switch—A Comparison Using Real-world Patient- and Physician-Reported Data in European Countries

Overview of attention for article published in Rheumatology and Therapy, January 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#41 of 559)
High Attention Score compared to outputs of the same age (91st percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news: 2 news outlets

twitter: 3 X users

Citations

dimensions_citation: 1 Dimensions

Readers on

mendeley: 4 Mendeley

Summary News X Dimensions citations

So far, Dimensions has found 1 citation of this research output.

1

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.